Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26917| Title: | OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy. | Austin Authors: | Ray, Jason C ;Hutton, Elspeth J;Matharu, Manjit | Affiliation: | The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK Department of Neurology, Alfred Hospital, Melbourne, VIC 3004, Australia Neurology Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia Headache and Facial Pain Group, University College London (UCL) Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK |
Issue Date: | 29-Jun-2021 | Date: | 2021-06-29 | Publication information: | Journal of Clinical Medicine 2021; 10(13): 2898 | Abstract: | The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emerging fortuitously from clinical observation is now supported by class one evidence and over two decades of real-world clinical data. There is still limited ability to predict a clinically meaningful response to OnaB-A for individual patients, however. This review summarises briefly the proposed mechanism of OnaB-A in chronic migraine, the literature of predictors of clinical response, and recent developments in the field. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26917 | DOI: | 10.3390/jcm10132898 | ORCID: | 0000-0003-4833-5507 0000-0002-8543-7767 0000-0002-4960-2294 |
Journal: | Journal of Clinical Medicine | PubMed URL: | 34209849 | ISSN: | 2077-0383 | Type: | Journal Article | Subjects: | botulinum toxin migraine predictors of efficacy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.